These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31148582)

  • 21. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer.
    Zhou T; Zhan J; Hong S; Hu Z; Fang W; Qin T; Ma Y; Yang Y; He X; Zhao Y; Huang Y; Zhao H; Zhang L
    Sci Rep; 2015 Jun; 5():10481. PubMed ID: 26084991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of C-reactive protein/albumin ratio for patients with hypopharyngeal and laryngeal cancer undergoing invasive surgery involving laryngectomy.
    Kuboki A; Kanaya H; Nakayama T; Konno W; Goto K; Nakajima I; Kashiwagi T; Hirabayashi H; Haruna SI
    Head Neck; 2019 May; 41(5):1342-1350. PubMed ID: 30552844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.
    Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F
    Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
    Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
    J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.
    Bittoni MA; Focht BC; Clinton SK; Buckworth J; Harris RE
    Int J Oncol; 2015 Oct; 47(4):1537-44. PubMed ID: 26323323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
    Gao N; Yang RN; Meng Z; Wang WH
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating C-reactive protein increases lung cancer risk: Results from a prospective cohort of UK Biobank.
    Ji M; Du L; Ma Z; Xie J; Huang Y; Wei X; Jiang X; Xu J; Yin R; Wang Y; Dai J; Jin G; Xu L; Zhu C; Hu Z; Ma H; Zhu M; Shen H
    Int J Cancer; 2022 Jan; 150(1):47-55. PubMed ID: 34449869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis.
    Leuzzi G; Galeone C; Gisabella M; Duranti L; Taverna F; Suatoni P; Morelli D; Pastorino U
    Tumori; 2016 Oct; 102(5):441-449. PubMed ID: 27292573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
    Xu XL; Yu HQ; Hu W; Song Q; Mao WM
    PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
    Jiang AG; Chen HL; Lu HY
    BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
    Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
    J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.
    Chi PD; Liu W; Chen H; Zhang JP; Lin Y; Zheng X; Liu W; Dai S
    PLoS One; 2014; 9(3):e91080. PubMed ID: 24625581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preoperative C-reactive protein/albumin ratio predicts the prognosis of patients with resectable pancreatic cancer].
    Luo BY; Yang Y; Duan YF; Cai HH; An Y; Sun DL
    Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):712-717. PubMed ID: 30157579
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
    Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
    Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does C reactive protein/Albumin ratio have prognostic value in patients with COVID-19.
    Kalabin A; Mani VR; Valdivieso SC; Donaldson B
    J Infect Dev Ctries; 2021 Aug; 15(8):1086-1093. PubMed ID: 34516415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
    Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
    Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
    PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
    Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.